Placebo-Controlled Trial of Urolithin A Supplementation in Men With Prostate Cancer Undergoing Radical Prostatectomy, URO-PRO Trial
Condition: Prostate Adenocarcinoma Interventions: Procedure: Biopsy; Procedure: Biospecimen Collection; Drug: Placebo Administration; Dietary Supplement: Urolithin A Supplement Sponsor: National Cancer Institute (NCI) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Adenocarcinoma | Cancer | Cancer & Oncology | Nutrition | Prostate Cancer | Prostatectomy | Research